Skip to main content

Evidence-Based Supplement Research

Evidence-Based Supplement Research

Correction: Improvement of loperamide-induced slow transit constipation by Bifidobacterium bifidum G9-1 is mediated by the correction of butyrate production and neurotransmitter profile due to improvement in dysbiosis.

2022-04-27
PloS one 17(4)
- Yutaka Makizaki
- Taiki Uemoto
- Haruka Yokota
- Miyuki Yamamoto
- Yoshiki Tanaka
- Hiroshi Ohno

PubMed: 35476793
DOI: 10.1371/journal.pone.0267927

[This corrects the article DOI: 10.1371/journal.pone.0248584.].

Research Insights

Bifidobacterium bifidum G9-1→Improved Chronic Constipation
Improvement of loperamide-induced slow transit constipation by Bifidobacterium bifidum G9-1 is mediated by the correction of butyrate production and neurotransmitter profile due to improvement in dysbiosis.
Effect
Beneficial
Effect size
Moderate
Bifidobacterium bifidum G9-1→Improved Gut Microbiome
improvement in dysbiosis
Effect
Beneficial
Effect size
Moderate
Bifidobacterium bifidum G9-1→Improved Neurotransmitter Profile
correction of ... neurotransmitter profile
Effect
Beneficial
Effect size
Moderate
Bifidobacterium bifidum G9-1→Improved Transit Time
Bifidobacterium bifidum G9-1 improved slow transit constipation
Effect
Beneficial
Effect size
Moderate
Bifidobacterium bifidum G9-1→Increased Butyrate Production
correction of butyrate production
Effect
Beneficial
Effect size
Moderate